273 related articles for article (PubMed ID: 16002005)
1. Induction chemotherapy for head and neck cancer: will history repeat itself?
Argiris A
J Natl Compr Canc Netw; 2005 May; 3(3):393-403. PubMed ID: 16002005
[TBL] [Abstract][Full Text] [Related]
2. Revisiting induction chemotherapy for head and neck cancer. References and reviews.
Argiris A; Jayaram P; Pichardo D
Oncology (Williston Park); 2005 Jun; 19(7):932-4, 939; discussion 939-45. PubMed ID: 16053039
[TBL] [Abstract][Full Text] [Related]
3. Revisiting induction chemotherapy for head and neck cancer.
Argiris A; Jayaram P; Pichardo D
Oncology (Williston Park); 2005 May; 19(6):759-70. PubMed ID: 15971451
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review.
Winquist E; Agbassi C; Meyers BM; Yoo J; Chan KKW;
J Otolaryngol Head Neck Surg; 2017 Apr; 46(1):29. PubMed ID: 28376866
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in locally advanced head and neck squamous cell carcinoma.
Gyawali B; Shimokata T; Honda K; Ando Y
Cancer Treat Rev; 2016 Mar; 44():10-6. PubMed ID: 26924194
[TBL] [Abstract][Full Text] [Related]
6. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
Mody MD; Gill HS; Saba NF
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
[TBL] [Abstract][Full Text] [Related]
9. Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation.
Ko EC; Genden EM; Misiukiewicz K; Som PM; Kostakoglu L; Chen CT; Packer S; Kao J
Oncol Rep; 2012 Feb; 27(2):467-74. PubMed ID: 22020564
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer.
Jain P; Kumar P; Pai VR; Parikh PM
Indian J Cancer; 2008; 45(3):83-9. PubMed ID: 19018109
[TBL] [Abstract][Full Text] [Related]
11. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M
Clin Oncol (R Coll Radiol); 2005 May; 17(3):148-52. PubMed ID: 15900997
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy: to use or not to use? That is the question.
Brizel DM; Vokes EE
Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy for head and neck cancer: recent data.
Vokes EE
Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
[TBL] [Abstract][Full Text] [Related]
16. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.
Posner MR
Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867
[TBL] [Abstract][Full Text] [Related]
17. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
Argiris A; Haraf DJ; Kies MS; Vokes EE
Oncologist; 2003; 8(4):350-60. PubMed ID: 12897332
[TBL] [Abstract][Full Text] [Related]
18. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update.
Bernier J
Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622
[TBL] [Abstract][Full Text] [Related]
19. Overview of combined modality therapies for head and neck cancer.
Dimery IW; Hong WK
J Natl Cancer Inst; 1993 Jan; 85(2):95-111. PubMed ID: 8418313
[TBL] [Abstract][Full Text] [Related]
20. Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review.
Behera M; Owonikoko TK; Kim S; Chen Z; Higgins K; Ramalingam SS; Shin DM; Khuri FR; Beitler JJ; Saba NF
Oral Oncol; 2014 Sep; 50(9):888-94. PubMed ID: 25060589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]